NCT06585189 CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS4] Status COMPLETED Phase N/A
NCT06581042 Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease in Belgium Status RECRUITING Phase N/A
NCT06579300 A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088 Status TERMINATED Phase PHASE1
NCT06575192 Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants Status RECRUITING Phase PHASE3
NCT06571266 A Study to Assess the Relative Bioavailability of Two Formulations of Risankizumab Following Subcutaneous Administration With Prefilled Syringes in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT06568939 A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Status RECRUITING Phase PHASE2
NCT06548568 A Real-world Study to Assess Safety of OZURDEX® (Dexamethasone Intravitreal Implant) in Adult Participants With Diabetic Macular Edema in China Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06548542 Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease Status RECRUITING Phase PHASE2
NCT06547125 A Study to Assess Adverse Events and Effectiveness of Intradermally Injected JUVÉDERM® VOLITE™ Gel Filler in Adult Participants For the Improvement of Skin Quality Status COMPLETED Phase PHASE2/PHASE3
NCT06543914 Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine Status RECRUITING Phase N/A
NCT06536049 Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma Status RECRUITING Phase PHASE1/PHASE2
NCT06524635 A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab Status RECRUITING Phase PHASE2
NCT06522386 GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Previously Untreated Mantle Cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06511882 Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD Status RECRUITING Phase PHASE2
NCT06510309 Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma Status RECRUITING Phase PHASE2
NCT06508658 A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06504459 Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML Status RECRUITING Phase PHASE2
NCT06503536 A Study to Assess Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization in Chinese Participants Receiving Upadacitinib for Atopic Dermatitis (AD) Through Chart Review Status COMPLETED Phase N/A
NCT06487572 A Study to Assess Pharmacokinetic Exposures Following Intravenous and Subcutaneous Administration of Risankizumab in Healthy Participants Status COMPLETED Phase PHASE1